Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:I-120-I-124
doi: 10.1161/CIRCULATIONAHA.105.000646
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guarita-Souza, L.C.
Right arrow Articles by Brofman, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guarita-Souza, L.C.
Right arrow Articles by Brofman, P.
Related Collections
Right arrow Contractile function
Right arrow Other heart failure
Right arrow Angiogenesis
Right arrow Heart failure - basic studies
Right arrow Myogenesis

(Circulation. 2006;114:I-120 – I-124.)
© 2006 American Heart Association, Inc.


Cell Transplantation and Tissue Engineering

Simultaneous Autologous Transplantation of Cocultured Mesenchymal Stem Cells and Skeletal Myoblasts Improves Ventricular Function in a Murine Model of Chagas Disease

L.C. Guarita-Souza, MD, PhD; K.A.T. Carvalho, MD; V. Woitowicz, MD; C. Rebelatto, BSc; A. Senegaglia, BSc; P. Hansen, BSc; N. Miyague, MD, PhD; J.C. Francisco, BSc; M. Olandoski, BSc; J.R. Faria-Neto, MD, PhD; P. Brofman, MD, PhD

From Experimental Laboratory of Cell Culture Institute of Biological and Health Sciences. Pontificia Universidade Catolica do Paraná (PUCPR), Brazil.

Correspondence to Luis César Guarita Souza, Rua Silveira Peixoto, 1062, ap 162, CEP: 80240-120, Curitiba (Pr), Brazil. E-mail llccggss{at}hotmail.com

Background— Cellular transplantation is emerging as a promising strategy for the treatment of postinfarction ventricular dysfunction. Whether its beneficial effects can be extended to other cardiomyopathies remains an unexplored question. We evaluated the histological and functional effects of simultaneous autologous transplantation of co-cultured stem cells and skeletal myoblasts in an experimental model of dilated cardiomyopathy caused by Chagas disease, characterized by diffuse fibrosis and impairment of microcirculation.

Methods and Results— Wistar rats weighing 200 grams were infected intraperitoneally with 15x104 trypomastigotes. After 8 months, 2-dimensional echocardiographic study was performed for baseline assessment of left ventricle (LV) ejection fraction (EF) (%), left ventricle end-diastolic volume (LVEDV) (mL), and left ventricle end-systolic volume (LVESV) (mL). Animals with LV dysfunction (EF <37%) were selected for the study. Autologous skeletal myoblasts were isolated from muscle biopsy and mesenchymal stem cells from bone marrow aspirates were co-cultured in vitro for 14 days, yielding a cell viability of >90%. Eleven animals received autologous transplant of 5.4x106±8.0x106 cells (300 µL) into the LV wall. The control group (n=10) received culture medium (300 µL). Cell types were identified with vimentin and fast myosin. After 4 weeks, ventricular function was reassessed by echo. For histological analysis, heart tissue was stained with hematoxylin and eosin and immunostained for fast myosin. After 4 weeks, cell transplantation significantly improved EF and reduced LVEDV and LVESV. No change was observed in the control group.

Conclusion— The co-transplant of stem cells and skeletal myoblasts is functionally effective in the Chagas disease ventricular dysfunction.


Key Words: cells • Chagas disease • heart failure • transplantation